FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sophie Lotersztajn

Research Profile

Anatomy

Chemicals & Drugs

Disorders

Living Beings

Concepts & Ideas

Kinetics

Co-author Network

Publications

TOP 3
Sophie Lotersztajn; Paul A Insel
AJP-Cell begins a theme series on tissue fibrosis.
Alain Luciani; Nathalie Luciani; Ariane Mallat; Sylvie Manin; Christine Péchoux; Marie Poirier-Quinot; Alain Rahmouni; Claire Wilhelm; Gwennhael Autret; Sebastien Ballet; Olivier Clément; Sophie Dechoux; Vanessa Deveaux; Michael Levy; Sophie Lotersztajn; Florence Gazeau
Adipose tissue macrophages: MR tracking to monitor obesity-associated inflammation.
Ariane Mallat; Sophie Lotersztajn
The liver X receptor in hepatic stellate cells: a novel antifibrogenic target?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sophie Lotersztajn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sophie Lotersztajn; Paul A Insel
AJP-Cell begins a theme series on tissue fibrosis.
American journal of physiology. Cell physiology 2013;304(3):C215.
2012: Alain Luciani; Nathalie Luciani; Ariane Mallat; Sylvie Manin; Christine Péchoux; Marie Poirier-Quinot; Alain Rahmouni; Claire Wilhelm; Gwennhael Autret; Sebastien Ballet; Olivier Clément; Sophie Dechoux; Vanessa Deveaux; Michael Levy; Sophie Lotersztajn; Florence Gazeau
Adipose tissue macrophages: MR tracking to monitor obesity-associated inflammation.
Radiology 2012;263(3):786-93.
2011: Ariane Mallat; Sophie Lotersztajn
The liver X receptor in hepatic stellate cells: a novel antifibrogenic target?
Journal of hepatology 2011;55(6):1452-4.
2011: Alexandre Louvet; Ariane Mallat; Catherine Pavoine; Françoise Pecker; Fatima Teixeira-Clerc; Andreas Zimmer; Marie-Noële Chobert; Vanessa Deveaux; Sophie Lotersztajn
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice.
Hepatology (Baltimore, Md.) 2011;54(4):1217-26.
2011: Ariane Mallat; S Manin; Fatima Teixeira-Clerc; Vanessa Deveaux; Sophie Lotersztajn
The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings.
British journal of pharmacology 2011;163(7):1432-40.
2011: Michael Levy; Nathalie Luciani; Damien Alloyeau; Dan Elgrabli; Vanessa Deveaux; Christine Pechoux; Sophie Chat; Guillaume Wang; Nidhi Vats; François Gendron; Cécile Factor; Sophie Lotersztajn; Alain Luciani; Claire Wilhelm; Florence Gazeau
Long term in vivo biotransformation of iron oxide nanoparticles.
Biomaterials 2011;32(16):3988-99.
2011: Bani Mukhopadhyay; Resat Cinar; Shi Yin; Jie Liu; Joseph Tam; Grzegorz Godlewski; Judith Harvey-White; Isioma Mordi; Benjamin F Cravatt; Sophie Lotersztajn; Bin Gao; Qiaoping Yuan; Kornel E Schuebel; David Goldman; George Kunos
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(15):6323-8.
2010: Fatima Teixeira-Clerc; Marie-Pierre Belot; Sylvie Manin; Vanessa Deveaux; Thomas Cadoudal; Marie-Noele Chobert; Alexandre Louvet; Andreas Zimmer; Thierry Tordjmann; Ariane Mallat; Sophie Lotersztajn
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration.
Hepatology (Baltimore, Md.) 2010;52(3):1046-59.
2010: Amélie Servettaz; Niloufar Kavian; Carole Nicco; Vanessa Deveaux; Christiane Chéreau; Andrew Wang; Andreas Zimmer; Sophie Lotersztajn; Bernard Weill; Frédéric Batteux
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.
The American journal of pathology 2010;177(1):187-96.
2010: Sophie Lotersztajn; Paul A Insel
American Journal of Physiology-Cell Physiology initiates a series of articles around a theme: autophagy is the first theme.
American journal of physiology. Cell physiology 2010;298(4):C775.
2010: M Ujue Latasa; Carmen Gil-Puig; Maite G Fernández-Barrena; Carlos M Rodríguez-Ortigosa; Jesús M Banales; Raquel Urtasun; Saioa Goñi; Miriam Méndez; Sara Arcelus; Nerea Juanarena; Juan Recio; Sophie Lotersztajn; Jesús Prieto; Carmen Berasain; Fernando J Corrales; Jon Lecanda; Matías A Avila
Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.
PloS one 2010;5(12):e15690.
2010: Ariane Mallat; Sophie Lotersztajn
Endocannabinoids and their role in fatty liver disease.
Digestive diseases (Basel, Switzerland) 2010;28(1):261-6.
2009: Ariane Mallat; Sophie Lotersztajn
Cigarette smoke exposure: a novel cofactor of NAFLD progression?
Journal of hepatology 2009;51(3):430-2.
2009: Nicole Defer; Jinghong Wan; Richard Souktani; Brigitte Escoubet; Magali Perier; Philippe Caramelle; Sylvie Manin; Vanessa Deveaux; Marie-Claude Bourin; Andreas Zimmer; Sophie Lotersztajn; Françoise Pecker; Catherine Pavoine
The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(7):2120-30.
2009: Vanessa Deveaux; Thomas Cadoudal; Yasukatsu Ichigotani; Fatima Teixeira-Clerc; Alexandre Louvet; Sylvie Manin; Jeanne Tran Van Nhieu; Marie Pierre Belot; Andreas Zimmer; Patrick Even; Patrice D Cani; Claude Knauf; Remy Burcelin; Adeline Bertola; Yannick Le Marchand-Brustel; Philippe Gual; Ariane Mallat; Sophie Lotersztajn
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.
PloS one 2009;4(6):e5844.
2009: Adeline Bertola; Vanessa Deveaux; Stéphanie Bonnafous; Déborah Rousseau; Rodolphe Anty; Abdelilah Wakkach; Moncef Dahman; Joan Tordjman; Karine Clément; Siobhán E McQuaid; Keith N Frayn; Pierre-Michel Huet; Jean Gugenheim; Sophie Lotersztajn; Yannick Le Marchand-Brustel; Albert Tran; Philippe Gual
Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity.
Diabetes 2009;58(1):125-33.
2008: Maria J Perugorria; M Ujue Latasa; Alexandra Nicou; Hugo Cartagena-Lirola; Josefa Castillo; Saioa Goñi; Umberto Vespasiani Gentilucci; Maria G Zagami; Sophie Lotersztajn; Jesús Prieto; Carmen Berasain; Matías A Avila
The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
Hepatology (Baltimore, Md.) 2008;48(4):1251-61.
2008: Ariane Mallat; Sophie Lotersztajn
Cannabinoid receptors as therapeutic targets in the management of liver diseases.
Drug news & perspectives 2008;21(7):363-8.
2008: Ariane Mallat; Christophe Hezode; Sophie Lotersztajn
Environmental factors as disease accelerators during chronic hepatitis C.
Journal of hepatology 2008;48(4):657-65.
2008: Werner I Hagens; Leonie Beljaars; D A Mann; Matthew C Wright; Boris Julien; Sophie Lotersztajn; Catharina Reker-Smit; Klaas Poelstra
Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers.
The Journal of pharmacology and experimental therapeutics 2008;324(3):902-10.
2008: Christophe Hézode; Elie Serge Zafrani; Françoise Roudot-Thoraval; Charlotte Costentin; Ali Hessami; Magali Bouvier-Alias; Fatiha Medkour; Jean-Michel Pawlostky; Sophie Lotersztajn; Ariane Mallat
Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.
Gastroenterology 2008;134(2):432-9.
2008: Ariane Mallat; Sophie Lotersztajn
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver.
American journal of physiology. Gastrointestinal and liver physiology 2008;294(1):G9-G12.
2008: Sophie Lotersztajn; Fatima Teixeira-Clerc; Boris Julien; Vanessa Deveaux; Y Ichigotani; S Manin; Jeanne Tran Van Nhieu; Meliha Karsak; Andreas Zimmer; Ariane Mallat
CB2 receptors as new therapeutic targets for liver diseases.
British journal of pharmacology 2008;153(2):286-9.
2007: Valérie Serriere-Lanneau; Fatima Teixeira-Clerc; Liying Li; Marlies Schippers; Willie de Wries; Boris Julien; Jeanne Tran Van Nhieu; Sylvie Manin; Klaas Poelstra; Jerold Chun; Stéphane Carpentier; Thierry Levade; Ariane Mallat; Sophie Lotersztajn
The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(9):2005-13.
2007: Sophie Lotersztajn; Fatima Teixeira-Clerc; Christophe Hezode; Jeanne Tran Van Nhieu; Vanessa Deveaux; Ariane Mallat
[Endocannabinoids: therapeutic perspectives in chronic liver diseases].
Gastroentérologie clinique et biologique 2007;31(3):255-8.
2007: Ariane Mallat; Fatima Teixeira-Clerc; Vanessa Deveaux; Sophie Lotersztajn
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases.
Expert opinion on therapeutic targets 2007;11(3):403-9.
2006: Fatima Teixeira-Clerc; Boris Julien; Pascale Grenard; Jeanne Tran Van Nhieu; Vanessa Deveaux; Liying Li; Valérie Serriere-Lanneau; Catherine Ledent; Ariane Mallat; Sophie Lotersztajn
[CB1 cannabinoid receptor antagonists: a novel approach for the treatment of liver fibrosis].
Médecine sciences : M/S 2006;22(8-9):683-5.
2006: Fatima Teixeira-Clerc; Boris Julien; Pascale Grenard; Jeanne Tran Van Nhieu; Vanessa Deveaux; Liying Li; Valérie Serriere-Lanneau; Catherine Ledent; Ariane Mallat; Sophie Lotersztajn
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis.
Nature medicine 2006;12(6):671-6.
2006: Ariane Mallat; Sophie Lotersztajn
Endocannabinoids as novel mediators of liver diseases.
Journal of endocrinological investigation 2006;29(3 Suppl):58-65.
2005: Christophe Hézode; Françoise Roudot-Thoraval; Son Nguyen; Pascale Grenard; Boris Julien; Elie Serge Zafrani; Jean-Michel Pawlotsky; Jean-Michel Pawlostky; Daniel Dhumeaux; Sophie Lotersztajn; Ariane Mallat
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2005;42(1):63-71.
2005: Boris Julien; Pascale Grenard; Fatima Teixeira-Clerc; Jeanne Tran Van Nhieu; Liying Li; Meliha Karsak; Andreas Zimmer; Ariane Mallat; Sophie Lotersztajn
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
Gastroenterology 2005;128(3):742-55.
2005: Sophie Lotersztajn; Boris Julien; Fatima Teixeira-Clerc; Pascale Grenard; Ariane Mallat
Hepatic fibrosis: molecular mechanisms and drug targets.
Annual review of pharmacology and toxicology 2005;45():605-28.
2004: Liying Li; Boris Julien; Pascale Grenard; Fatima Teixeira-Clerc; Ariane Mallat; Sophie Lotersztajn
Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts.
Journal of hepatology 2004;41(3):407-13.
2003: Liying Li; Pascale Grenard; Jeanne Tran Van Nhieu; Boris Julien; Ariane Mallat; Aida Habib; Sophie Lotersztajn
Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts.
Gastroenterology 2003;125(2):460-9.
2002: Julien Davaille; Liying Li; Ariane Mallat; Sophie Lotersztajn
Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts.
The Journal of biological chemistry 2002;277(40):37323-30.
2001: Liying Li; J Tao; Julien Davaille; C Feral; Ariane Mallat; J Rieusset; Hubert Vidal; Sophie Lotersztajn
15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors.
The Journal of biological chemistry 2001;276(41):38152-8.
2000: Julien Davaille; C Gallois; Aida Habib; Liying Li; Ariane Mallat; J Tao; Thierry Levade; Sophie Lotersztajn
Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway.
The Journal of biological chemistry 2000;275(44):34628-33.
2000: C Gallois; Julien Davaille; Aida Habib; Ariane Mallat; J Tao; Thierry Levade; Sophie Lotersztajn
Endothelin-1 stimulates sphingosine kinase in human hepatic stellate cells. A novel role for sphingosine-1-P as a mediator of growth inhibition.
Annals of the New York Academy of Sciences 2000;905():311-4.
1999: J Tao; Ariane Mallat; C Gallois; Souad Belmadani; Pierre-François Méry; Jeanne Tran Van Nhieu; Catherine Pavoine; Sophie Lotersztajn
Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cells.
The Journal of biological chemistry 1999;274(34):23761-9.
1998: Ariane Mallat; C Gallois; J Tao; Aida Habib; Jacques Maclouf; Philippe Mavier; Anne-Marie Préaux; Sophie Lotersztajn
Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors.
The Journal of biological chemistry 1998;273(42):27300-5.
1998: C Gallois; Aida Habib; J Tao; S Moulin; Jacques Maclouf; Ariane Mallat; Sophie Lotersztajn
Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.
The Journal of biological chemistry 1998;273(36):23183-90.
1996: Ariane Mallat; Anne-Marie Préaux; Claudine Serradeil-Le Gal; Danielle Raufaste; C Gallois; David A Brenner; C Bradham; Jacques Maclouf; V Iourgenko; L Fouassier; Daniel Dhumeaux; Philippe Mavier; Sophie Lotersztajn
Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors.
The Journal of clinical investigation 1996;98(12):2771-8.
1996: Ariane Mallat; Sophie Lotersztajn
Multiple hepatic functions of endothelin-1: physiopathological relevance.
Journal of hepatology 1996;25(3):405-13.
1995: Ariane Mallat; L Fouassier; Anne-Marie Préaux; C S Gal; Danielle Raufaste; Jean Rosenbaum; Daniel Dhumeaux; C Jouneaux; Philippe Mavier; Sophie Lotersztajn
Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway.
The Journal of clinical investigation 1995;96(1):42-9.
1995: Ariane Mallat; L Fouassier; Anne-Marie Préaux; Philippe Mavier; Sophie Lotersztajn
Antiproliferative effects of ET-1 in human liver Ito cells: an ETB- and a cyclic AMP-mediated pathway.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S132-4.
1994: Marielle Gascon-Barré; P Haddad; S J Provencher; S Bilodeau; Françoise Pecker; Sophie Lotersztajn; S Vallières
Chronic hypocalcemia of vitamin D deficiency leads to lower intracellular calcium concentrations in rat hepatocytes.
The Journal of clinical investigation 1994;93(5):2159-67.
1994: C Jouneaux; Ariane Mallat; Claudine Serradeil-Le Gal; P Goldsmith; Jacques Hanoune; Sophie Lotersztajn
Coupling of endothelin B receptors to the calcium pump and phospholipase C via Gs and Gq in rat liver.
The Journal of biological chemistry 1994;269(3):1845-51.
1993: C Jouneaux; Y Audigier; P Goldsmith; Françoise Pecker; Sophie Lotersztajn
Gs mediates hormonal inhibition of the calcium pump in liver plasma membranes.
The Journal of biological chemistry 1993;268(4):2368-72.
1993: Sophie Lotersztajn
[Endothelins and their non-vascular effects].
Pathologie-biologie 1993;41(2):143-8.
1993: C Jouneaux; P Goldsmith; Jacques Hanoune; Sophie Lotersztajn
Endothelin inhibits the calcium pump and stimulates phosphoinositide phospholipase C in liver plasma membranes via two different G proteins, Gs and Gq.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S158-60.
1992: C Jouneaux; Claudine Serradeil-Le Gal; Danielle Raufaste; C Garcia; Anne-Marie Préaux; Jacques Hanoune; Sophie Lotersztajn
Biological effects of sarafotoxin in rat liver.
Biochemical pharmacology 1992;43(5):1146-8.
1992: Sophie Lotersztajn; Catherine Pavoine; P Deterre; J Capeau; Ariane Mallat; D LeNguyen; M Dufour; B Rouot; Dominique Bataille; Françoise Pecker
Role of G protein beta gamma subunits in the regulation of the plasma membrane Ca2+ pump.
The Journal of biological chemistry 1992;267(4):2375-9.
1991: Claudine Serradeil-Le Gal; C Jouneaux; A Sanchez-Bueno; Danielle Raufaste; B Roche; Anne-Marie Préaux; Jean-Pierre Maffrand; P H Cobbold; Jacques Hanoune; Sophie Lotersztajn
Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.
The Journal of clinical investigation 1991;87(1):133-8.
1990: philippe blache; A Kervran; M Dufour; J Martinez; Dung Le-Nguyen; Sophie Lotersztajn; Catherine Pavoine; Françoise Pecker; Dominique Bataille
Glucagon-(19-29), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase.
The Journal of biological chemistry 1990;265(35):21514-9.
1990: V Brechler; Catherine Pavoine; Sophie Lotersztajn; E Garbarz; Françoise Pecker
Activation of Na+/Ca2+ exchange by adenosine in ewe heart sarcolemma is mediated by a pertussis toxin-sensitive G protein.
The Journal of biological chemistry 1990;265(28):16851-5.
1990: Sophie Lotersztajn; Catherine Pavoine; V Brechler; B Roche; M Dufour; Dung Le-Nguyen; Dominique Bataille; Françoise Pecker
Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins.
The Journal of biological chemistry 1990;265(17):9876-80.
1990: R C McKenzie; Sophie Lotersztajn; Catherine Pavoine; Françoise Pecker; Richard M Epand; R C Orlowski
Inhibition of the calcium pump by human parathyroid hormone-(1-34) and human calcitonin in liver plasma membranes.
The Biochemical journal 1990;266(3):817-22.
1989: Catherine Pavoine; V Brechler; B Roche; Sophie Lotersztajn; Françoise Pecker
[Hepatic cytoprotection (5). Calcium and hepatotoxicity].
Gastroentérologie clinique et biologique 1989;13(8-9):720-4.
1989: philippe blache; A Kervran; M Dufour; J Martinez; Dung Le-Nguyen; Sophie Lotersztajn; Catherine Pavoine; Françoise Pecker; Dominique Bataille
[Glucagon is processed to the (19-29) fragment at the level of the hepatocyte membrane].
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1989;308(17):467-72.
1988: Dominique Bataille; philippe blache; F Mercier; Claire Jarrousse; A Kervran; M Dufour; Paul Mangeat; M Dubrasquet; Ariane Mallat; Sophie Lotersztajn
Glucagon and related peptides. Molecular structure and biological specificity.
Annals of the New York Academy of Sciences 1988;527():168-85.
1988: Sophie Lotersztajn; Catherine Pavoine; Ariane Mallat; Françoise Pecker
Regulation of liver plasma membrane Ca2+ pump.
Advances in experimental medicine and biology 1988;232():69-82.
1987: Ariane Mallat; Catherine Pavoine; Sophie Lotersztajn; Françoise Pecker
[Calcium and cell death].
Gastroentérologie clinique et biologique 1987;11(6-7):445-8.
1987: Catherine Pavoine; Sophie Lotersztajn; Ariane Mallat; Françoise Pecker
The high affinity (Ca2+-Mg2+)-ATPase in liver plasma membranes is a Ca2+ pump. Reconstitution of the purified enzyme into phospholipid vesicles.
The Journal of biological chemistry 1987;262(11):5113-7.
1987: Sophie Lotersztajn; Catherine Pavoine; Ariane Mallat; D Stengel; P A Insel; Françoise Pecker
Cholera toxin blocks glucagon-mediated inhibition of the liver plasma membrane (Ca2+-Mg2+)-ATPase.
The Journal of biological chemistry 1987;262(7):3114-7.
1987: Ariane Mallat; Catherine Pavoine; M Dufour; Sophie Lotersztajn; Dominique Bataille; Françoise Pecker
A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon.
Nature 1987;325(6105):620-2.
1985: Sophie Lotersztajn; R Epand; Ariane Mallat; Catherine Pavoine; Françoise Pecker
The liver plasma membrane Ca2+ pump: hormonal sensitivity.
Biochimie 1985;67(10-11):1169-76.
1985: Sophie Lotersztajn; Ariane Mallat; Catherine Pavoine; Françoise Pecker
The inhibitor of liver plasma membrane (Ca2+-Mg2+)-ATPase. Purification and identification as a mediator of glucagon action.
The Journal of biological chemistry 1985;260(17):9692-8.
1985: Françoise Pecker; Sophie Lotersztajn
Fe2+ and other divalent metal ions uncouple Ca2+ transport from (Ca2+-Mg2+)-ATPase in rat liver plasma membranes.
The Journal of biological chemistry 1985;260(2):731-5.
1984: Sophie Lotersztajn; R M Epand; Ariane Mallat; Françoise Pecker
Inhibition by glucagon of the calcium pump in liver plasma membranes.
The Journal of biological chemistry 1984;259(13):8195-201.
1982: Sophie Lotersztajn; Philippe Mavier; J Clergue; D Dhumeaux; Françoise Pecker
Human liver plasma membrane Ca-ATPase: identification and sensitivity to calcium antagonists.
Hepatology (Baltimore, Md.) 1982;2(6):843-8.
1982: Sophie Lotersztajn; Françoise Pecker
A membrane-bound protein inhibitor of the high affinity Ca ATPase in rat liver plasma membranes.
The Journal of biological chemistry 1982;257(12):6638-41.
1982: Françoise Pecker; Sophie Lotersztajn
The liver plasma membrane Ca-ATPase.
Annals of the New York Academy of Sciences 1982;402():438-9.
1981: Sophie Lotersztajn; J Hanoune; Françoise Pecker
A high affinity calcium-stimulated magnesium-dependent ATPase in rat liver plasma membranes. Dependence of an endogenous protein activator distinct from calmodulin.
The Journal of biological chemistry 1981;256(21):11209-15.